Losartan potassium 25 MG Oral Tablet — RxCUI 979485
RxNorm drug concept · Semantic clinical drug
RxCUI 979485
Semantic clinical drug · SCD
● Current RxNorm concept 132 FDA products
347 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI979485
Official nameLosartan potassium 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asLosartan K+ 25 MG Oral Tablet; Losartan Pot 25 MG Oral Tablet
FDA products mapped132
Package NDCs mapped347
Reported Medicaid activity (SDUD)5,992,816 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Losartan: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Losartan is mainly used to lower high blood pressure, which protects you from strokes and heart attacks over time. Depending on your situation, your doctor may also have prescribed...
- What exactly is losartan supposed to do for me?
- You can take losartan at any time of day that works for you, as long as you're consistent. Taking it with or without food is both fine — eating may slow things down a tiny bit, but...
- Does it matter what time of day I take it, and can I take it with food?
🕸️ Concept Web — How Losartan potassium 25 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Losartan potassium 25 MG Oral Tablet
RxCUI 979485 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Losartan
52175IN -
Losartan potassium
203160PIN
-
Losartan
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Cozaar
151558BN
-
Cozaar
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Losartan Oral Tablet
372651SCDF -
Losartan potassium Oral Tablet
2645428SCDFP -
Losartan Oral Product
1165342SCDG -
Losartan Pill
1165343SCDG -
Losartan potassium Oral Product
2659438SCDGP -
Losartan potassium Pill
2662025SCDGP -
Losartan Oral Tablet [Cozaar]
368240SBDF -
Losartan potassium Oral Tablet [Cozaar]
2656240SBDFP - +5 more in this family
-
Losartan Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Losartan potassium 25 MG
979484SCDC -
Losartan potassium 25 MG Oral Tablet [Cozaar]
979487SBD -
Losartan potassium 25 MG [Cozaar]
979486SBDC
-
Losartan potassium 25 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Losartan potassium 25 MG
SCDC · 979484 -
Losartan Oral Tablet
SCDF · 372651 -
Losartan potassium Oral Tablet
SCDFP · 2645428 -
Losartan Oral Product
SCDG · 1165342 -
Losartan Pill
SCDG · 1165343 -
Losartan potassium Oral Product
SCDGP · 2659438 -
Losartan potassium Pill
SCDGP · 2662025
Brand-Name Concepts
-
Losartan potassium 25 MG Oral Tablet [Cozaar]
SBD · 979487 -
Losartan potassium 25 MG [Cozaar]
SBDC · 979486 -
Losartan Oral Tablet [Cozaar]
SBDF · 368240 -
Losartan potassium Oral Tablet [Cozaar]
SBDFP · 2656240 -
Cozaar Oral Product
SBDG · 1172369 -
Cozaar Pill
SBDG · 1172370 -
Cozaar
BN · 151558
📦 FDA Products & Package NDCs
132 products · 347 package NDCs
347 package NDCs map to RxCUI 979485 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 33342-0045-07 | 30 TABLET, FILM COATED in 1 BOTTLE (33342-045-07) | Losartan potassium | Macleods Pharmaceuticals Limited | 2012-06-01 |
| 33342-0045-10 | 90 TABLET, FILM COATED in 1 BOTTLE (33342-045-10) | Losartan potassium | Macleods Pharmaceuticals Limited | 2012-06-01 |
| 33342-0045-12 | 10 BLISTER PACK in 1 CARTON (33342-045-12) / 10 TABLET, FIL... | Losartan potassium | Macleods Pharmaceuticals Limited | 2012-06-01 |
| 33342-0045-44 | 1000 TABLET, FILM COATED in 1 BOTTLE (33342-045-44) | Losartan potassium | Macleods Pharmaceuticals Limited | 2016-01-18 |
| 33342-0046-07 | 30 TABLET, FILM COATED in 1 BOTTLE (33342-046-07) | Losartan potassium | Macleods Pharmaceuticals Limited | 2012-06-01 |
| 33342-0046-10 | 90 TABLET, FILM COATED in 1 BOTTLE (33342-046-10) | Losartan potassium | Macleods Pharmaceuticals Limited | 2012-06-01 |
| 33342-0046-12 | 10 BLISTER PACK in 1 CARTON (33342-046-12) / 10 TABLET, FIL... | Losartan potassium | Macleods Pharmaceuticals Limited | 2012-06-01 |
| 33342-0046-44 | 1000 TABLET, FILM COATED in 1 BOTTLE (33342-046-44) | Losartan potassium | Macleods Pharmaceuticals Limited | 2016-01-18 |
| 42571-0110-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (42571-110-10) | LOSARTAN POTASSIUM | Micro Labs Limited | 2012-12-06 |
| 42571-0110-30 | 30 TABLET, FILM COATED in 1 BOTTLE (42571-110-30) | LOSARTAN POTASSIUM | Micro Labs Limited | 2012-12-06 |
| 42571-0110-90 | 90 TABLET, FILM COATED in 1 BOTTLE (42571-110-90) | LOSARTAN POTASSIUM | Micro Labs Limited | 2012-12-06 |
| 42571-0111-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (42571-111-10) | LOSARTAN POTASSIUM | Micro Labs Limited | 2012-12-06 |
| 42571-0111-30 | 30 TABLET, FILM COATED in 1 BOTTLE (42571-111-30) | LOSARTAN POTASSIUM | Micro Labs Limited | 2012-12-06 |
| 42571-0111-90 | 90 TABLET, FILM COATED in 1 BOTTLE (42571-111-90) | LOSARTAN POTASSIUM | Micro Labs Limited | 2012-12-06 |
| 42571-0112-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (42571-112-10) | LOSARTAN POTASSIUM | Micro Labs Limited | 2012-12-06 |
| 42571-0112-30 | 30 TABLET, FILM COATED in 1 BOTTLE (42571-112-30) | LOSARTAN POTASSIUM | Micro Labs Limited | 2012-12-06 |
| 42571-0112-90 | 90 TABLET, FILM COATED in 1 BOTTLE (42571-112-90) | LOSARTAN POTASSIUM | Micro Labs Limited | 2012-12-06 |
| 42708-0125-30 | 30 TABLET, FILM COATED in 1 BOTTLE (42708-125-30) | Losartan Potassium | QPharma, Inc. | 2018-05-23 |
| 42708-0151-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (42708-151-30) | Losartan Potassium | QPharma, Inc. | 2021-07-30 |
| 43547-0360-09 | 90 TABLET, FILM COATED in 1 BOTTLE (43547-360-09) | Losartan Potassium | Solco Healthcare US, LLC | 2022-03-20 |
| 43547-0360-11 | 1000 TABLET, FILM COATED in 1 BOTTLE (43547-360-11) | Losartan Potassium | Solco Healthcare US, LLC | 2022-03-20 |
| 43547-0360-50 | 500 TABLET, FILM COATED in 1 BOTTLE (43547-360-50) | Losartan Potassium | Solco Healthcare US, LLC | 2022-03-20 |
| 43547-0361-03 | 30 TABLET, FILM COATED in 1 BOTTLE (43547-361-03) | Losartan Potassium | Solco Healthcare US, LLC | 2022-03-20 |
| 43547-0361-09 | 90 TABLET, FILM COATED in 1 BOTTLE (43547-361-09) | Losartan Potassium | Solco Healthcare US, LLC | 2022-03-20 |
| 43547-0361-11 | 1000 TABLET, FILM COATED in 1 BOTTLE (43547-361-11) | Losartan Potassium | Solco Healthcare US, LLC | 2022-03-20 |
| 43547-0361-50 | 500 TABLET, FILM COATED in 1 BOTTLE (43547-361-50) | Losartan Potassium | Solco Healthcare US, LLC | 2022-03-20 |
| 43547-0362-03 | 30 TABLET, FILM COATED in 1 BOTTLE (43547-362-03) | Losartan Potassium | Solco Healthcare US, LLC | 2022-03-20 |
| 43547-0362-09 | 90 TABLET, FILM COATED in 1 BOTTLE (43547-362-09) | Losartan Potassium | Solco Healthcare US, LLC | 2022-03-20 |
| 43547-0362-11 | 1000 TABLET, FILM COATED in 1 BOTTLE (43547-362-11) | Losartan Potassium | Solco Healthcare US, LLC | 2022-03-20 |
| 43547-0362-50 | 500 TABLET, FILM COATED in 1 BOTTLE (43547-362-50) | Losartan Potassium | Solco Healthcare US, LLC | 2022-03-20 |
| 46708-0445-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-445-30) | Losartan Potassium | Alembic Pharmaceuticals Limited | 2016-05-23 |
| 46708-0445-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-445-31) | Losartan Potassium | Alembic Pharmaceuticals Limited | 2016-05-23 |
| 46708-0445-90 | 90 TABLET, FILM COATED in 1 BOTTLE (46708-445-90) | Losartan Potassium | Alembic Pharmaceuticals Limited | 2016-05-23 |
| 46708-0445-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-445-91) | Losartan Potassium | Alembic Pharmaceuticals Limited | 2016-05-23 |
| 46708-0446-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-446-30) | Losartan Potassium | Alembic Pharmaceuticals Limited | 2016-05-23 |
| 46708-0446-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-446-31) | Losartan Potassium | Alembic Pharmaceuticals Limited | 2016-05-23 |
| 46708-0446-90 | 90 TABLET, FILM COATED in 1 BOTTLE (46708-446-90) | Losartan Potassium | Alembic Pharmaceuticals Limited | 2016-05-23 |
| 46708-0446-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-446-91) | Losartan Potassium | Alembic Pharmaceuticals Limited | 2016-05-23 |
| 46708-0447-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-447-30) | Losartan Potassium | Alembic Pharmaceuticals Limited | 2016-05-23 |
| 46708-0447-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-447-31) | Losartan Potassium | Alembic Pharmaceuticals Limited | 2016-05-23 |
| 46708-0447-90 | 90 TABLET, FILM COATED in 1 BOTTLE (46708-447-90) | Losartan Potassium | Alembic Pharmaceuticals Limited | 2016-05-23 |
| 46708-0447-91 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-447-91) | Losartan Potassium | Alembic Pharmaceuticals Limited | 2016-05-23 |
| 50090-2622-00 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-2622-0) | Losartan Potassium | A-S Medication Solutions | 2016-12-07 |
| 50090-2622-01 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-2622-1) | Losartan Potassium | A-S Medication Solutions | 2016-11-16 |
| 50090-2622-02 | 100 TABLET, FILM COATED in 1 BOTTLE (50090-2622-2) | Losartan Potassium | A-S Medication Solutions | 2023-10-26 |
| 50090-4645-00 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-4645-0) | Losartan Potassium | A-S Medication Solutions | 2019-10-24 |
| 50090-4645-01 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-4645-1) | Losartan Potassium | A-S Medication Solutions | 2019-10-24 |
| 50090-4645-02 | 100 TABLET, FILM COATED in 1 BOTTLE (50090-4645-2) | Losartan Potassium | A-S Medication Solutions | 2023-12-07 |
| 50090-5626-00 | 30 TABLET in 1 BOTTLE (50090-5626-0) | Losartan Potassium | A-S Medication Solutions | 2021-09-01 |
| 50090-5626-01 | 90 TABLET in 1 BOTTLE (50090-5626-1) | Losartan Potassium | A-S Medication Solutions | 2021-09-01 |
Observed labelers:
Bryant Ranch Prepack (45) ·
A-S Medication Solutions (15) ·
Camber Pharmaceuticals, Inc. (15) ·
Zydus Lifesciences Limited (15) ·
Zydus Pharmaceuticals USA Inc. (15) ·
Aphena Pharma Solutions - Tennessee, LLC (13)
· +34 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.